Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
By 2020, about 20 percent of healthcare organizations will be using blockchain for operations management and patient identity, according to an IDC Health Insights report cited by ComputerWorld.
CMS is working on a program to allow Medicare beneficiaries to share their data with third-party apps—and it appears to be popular with developers. The effort, called Blue Button 2.0, has attracted 500 organizations and 700 developers who are interested in experimenting with the data.
Henry Ford Health System announced its first ever direct-to-employer healthcare contract in a deal with General Motors to deliver healthcare management and wellness services to Michigan GM employees and their families starting in 2019.
CMS and the Office of National Coordinator for Health Information Technology (ONC) are working to create a health ecosystem that allows patients to easily share their electronic health records (EHRs) with those who need them.
Health insurance giant Humana has filed suit against dozens of drug companies allegedly they conspired together to fix prices of generic drugs like antidepressants, muscle relaxers and skin treatments.
Hospitals that are involved in two bundled payment models are less likely to utilize skilled nursing facilities, according to a new study published in HealthAffairs.
As machine learning in dermatology begins to take off, researchers should remember to include all skin types when developing algorithms for identifying skin cancer, according to an Aug. 1 viewpoint published in JAMA.
